qXR-CTR vs Us2.v2
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are adjacent in their comparability, as both are FDA-cleared, AI-powered solutions for cardiology. However, qXR-CTR specifically focuses on automating cardiothoracic ratio measurements from chest X-ray images, while Us2.v2 automates the interpretation and reporting of echocardiograms. Therefore, the choice between them depends on the specific imaging modality being utilized for cardiac assessment.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
qXR-CTR analyzes chest X-ray images to automate the measurement of the cardiothoracic ratio (CTR). In contrast, Us2.v2 is an AI-powered tool that automates the interpretation of echocardiogram images.
qXR-CTR aids in the assessment of heart size and potential heart failure risk by providing automated CTR measurements. Us2.v2 delivers a complete structured echo report with measurements, disease detection for conditions such as cardiac amyloidosis, aortic stenosis, heart failure, pulmonary hypertension, and valvular disease, and clinical findings.
Us2.v2 integrates seamlessly with existing PACS, CVIS, or EMR systems, supporting HL7 and DICOM SR, and is compatible with any ultrasound manufacturer. qXR-CTR provides annotated X-rays and structured reports in DICOM and JSON formats, designed to integrate into existing radiology workflows.
Us2.v2 aims to reduce reporting time by up to 70% and increase daily scan throughput by providing 100% AI automation for echocardiogram interpretation. qXR-CTR focuses on delivering precise and efficient results for CTR assessment, which can save time for physicians and improve diagnostic accuracy.